Haven't read this one yet, but looks like a fantastic resource for everyone working with complex #spectral #flowcytometry panels!

One of the highlights of the annual SSI meeting is the recognition of researchers who have made significant contributions in the immunology field in Scandinavia. We want to extend our warmest congratulations to SWIMM member Chris Tibbitt @ki.se who was awarded the SSI Young Investigator Award 2025

CRATERs have been identified as sites of increased tumor antigen presentation where T cells can recognize and kill tumor cells bit.ly/3J8g42v  @ayaludin.bsky.social

Our new publication in @cp-immunity.bsky.social: Tertiary lymphoid structures with signs of functional adaptive immune responses in a subset of human gliomas. Association with longer overall patient survival and more immune-permissive tumor microenvironment. doi.org/10.1016/j.im...

📢📢FINAL CALL!! Closes tomorrow (Mon 20th Oct) Want a cool, blue skies project, integrating machine learning with virology to develop the medicines 💊of the future? Want to join a supportive team with an incredible culture? Apply now! 🧬🔬🧪🦠👨‍🔬👩‍🔬 www.findaphd.com/phds/project...

Our new review in @natbiomedeng.nature.com is out! RNA-loaded lipid nanoparticles (LNPs) have huge potential—but their strong liver and immune cell uptake has mostly confined them to vaccines and liver therapies. We explore how to move beyond those limits. free to read 🔗 rdcu.be/eLxGs

The #Scandinavian SSI #Immunology meeting has come to an end. Is has been 3 days full with amazing science from invited speakers, selected short talks, poster presentations, and social and network opportunities! We already look forward to the meeting in #Bergen! @ssi-immunology.bsky.social

1/2 Sharing exciting news! ✨ Our recently published paper “Anchored screening identifies transcription factor blueprints underlying dendritic cell diversity and subset-specific anti-tumor immunity” has been selected for the cover of the October issue of Immunity! @cp-immunity.bsky.social

Check out our latest in @cp-trendscancer.bsky.social where rockstar PhD student @laurarosenberg.bsky.social reviews cancer therapies known to induce innate immune responses through the reactivation of Transposable Elements.

So happy to share that our review in #ImmunolRev is finally out! 😃 We discuss how the immune system builds specialized TLSs across organs and conditions. Huge thanks to @StephanGuillaume, @iannaconelab.bsky.social & @linterman.bsky.social for this collaboration! dx.doi.org/10.1111/imr.70063

📢 The deadline to register for the annual meeting of the #Scandinavian Society of #Immunology is approaching fast! Join us for a great line up of invited speakers, short talks, networking activities, etc in beautiful #Stockholm! More info below 👇🏼

The laboratory of Filipe Pereira @lunduniversity.bsky.social in @cp-immunity.bsky.social "uncover transcriptional circuits that control DC diversification" Very cool approach and can't wait to hear more about it the next French DC society meeting👇 www.cfcd.fr/meeting/prog...

The registration deadline for the upcoming SSI 2025 meeting in Stockholm is coming up quickly! Register before the 12th of September 23:59 to attend the conference. The preliminary program has been published, so take a look on our website if you're curious: swimm.se/ssi2025-scie...

Can't get enough of #immunology? Join Global ImmunoTalks — a free, international webinar series featuring leading immunologists from around the world 🌍 🔬 Weekly talks 📅 Live & recorded sessions 🌐 Open to everyone Follow @globalimmuno.bsky.social for the latest updates! Starting today 👇🏼

Dendritic cells! What can’t they do?! In addition to being the surveilling determinants of self vs. non-self, they can degrade NETs, unmasking tumors protected by suppressive neutrophils. www.sciencedirect.com/science/arti...

Thrilled to share our new publication on the first-in-human phase 1 trial of intratumoral Fc-engineered CD40 agonistic antibody 2141-V11 in metastatic cancer. Over 10 years of preclinical work at the Ravetch lab led to this moment, made possible by an amazing team! 🧵 🪡 www.cell.com/cancer-cell/...

Really cool new paper @science.org on how platelets sequester ctDNA and can be used for screening and prediction purposes. Congrats to the authors! 👏 Link, and great thread below 👇🏼

🚨 Our new #preprint is out! doi.org/10.1101/2025... We used #PerturbMap spatial functional genomics in pancreatic cancer to track tumor clone dynamics and uncover how extracellular factors like Serpine1 and Serpinb2 drive immune evasion. 🧵 (1/8)

A striking new study showing that #virus infection can awaken dormant #cancer cells 🦠🧪 "Increased risk of cancer-related death in COVID+ individuals was most pronounced in the months immediately following infection, mirroring the rapid proliferation of reawakened cancer cells observed in the mice"

New protocol paper out from the Pereira lab. The protocol describes the in vivo #reprogramming of cancer cells into #DC1-like cells within the #TME through enforced expression of the transcription factors PU.1, IRF8, and BATF3. www.linkedin.com/posts/carlos...

The numbers of women in science falls substantially at the transition from postdoc to independent investigator/ PI So what can we do to prevent this? One initiative we now organise annually at #EACR is the highly successful 'Women in Leadership' workshop ⏬ #WomenInScience 🧪 @helloeacr.bsky.social

Some say you either have "it" or you don't, and that creativity cannot be learned, but that really misses the point. Creativity is lost in the wrong environment. We need to recognize the "night science" aspect of our work and that we need to nurture it in our training. www.nature.com/articles/d41...

It was a privilege and a pleasure for both myself and @menezesnmaria.bsky.social‬ to preview a great upcoming article in @cp-immunity.bsky.social‬ by @kamphorstlab.bsky.social‬ showing an unexpected inhibitory role for ICOS in exhausted CD8+ T cells. www.cell.com/immunity/abs...

SOX2 and NR2F1 cooperate to make #neurons in the #Thalamus for visual input from the #retina #DevBio journals.biologists.com/bio/article/... ‪ @biologyopen.bsky.social In collab w Sara Mercurio and Silvia Nicolis @btbsunimib.bsky.social Driven by Linda Serra and @annanordin.bsky.social

Our paper is out! Check out this beautiful story where we uncovered that the costimulatory molecule ICOS is detrimental for PD-1+ CD8 T cells. Sustained ICOS signaling reduces memory-like features of progenitor exhausted CD8 T cells in chronic viral infection and liver cancer.

Even though abstract submission has closed, registration for SSI 2025 is still open! Register now at swimm.se/ssi2025-regi... to hear inspiring talks, enjoy our social activities and learn about scandinavian immunology research!

🚨very nice story in @nature.com showing that "disruption of dendritic cells motility in tumors promotes immune evasion, and its enhancement offers a promising direction for DC-centric immunotherapy"🚨. www.nature.com/articles/s41...

🧠 Neuro-immunology is reshaping how we understand the brain - across many diseases, including #cancer In this research highlight 🧪🔬 we discuss a new study in #Nature by Remsik, Boire et al showing how IFNγ-activated immune cells in the CNS, incl DCs, help constrain leptomeningeal #metastasis

Are you looking to start your #lab in a fantastic scientific 🧪environment, with great colleagues, and in a spectacular place to live? Then check out our open #junior #faculty position at the Department of Oncology, University of Lausanne, Switzerland: www.unil.ch/dof/en/home/... ⏰ Deadline 27 June

Dear fellow immunologists! If you are fairly new to Bluesky and don't know who to follow, I can highly recommend #Immunology starter packs, curated by @rodrahimi.bsky.social Follow entire packs or scroll and select your favorites!

Early bird registration for the Annual SSI (Scandinavian #Immunology) meeting is appoaching! Don't miss this opportunity to listen to great speakers including Bart Lambrecht, Filipe Pereira, Susanne Brix, etc, in beautiful #Stockholm Early bird registration: Juli 1st Abstract deadline: June 30th

This year was the 7th Swedish Cancer Research Meeting #SCRM and for the first time @liu.se @liucancer.bsky.social took part in the national programme committee. A big thanks to Lund University Cancer Centre @lunduniversity.bsky.social for hosting this year’s gathering! This is our lab's insight:

The abstract submission deadline has been extended to June 29, 2025! Submit your abstract at: lnkd.in/gJKhjt-7

Trust in vaccines is being undermined.💉But what should you say to someone who has doubts? I spoke with vaccine hesitancy researchers for @nature.com to find out how best to speak to someone with questions /concerns about vaccines. Anyone can use their helpful advice www.nature.com/articles/d41...

In @cp-cellrepmed.bsky.social, IPBS researchers propose a treatment based on optimized antibodies that, in mice, increases the proportion of HEV blood vessels and facilitates killer cell entry into tumors. These molecules are currently in clinical trials ⤵️ buff.ly/Ip3US2l

Incoming - new preprint alert from the Parkes lab led by @brunobeernaert.bsky.social Full bluetutorial follows! 1/ 11 www.biorxiv.org/content/10.1...

The abstract deadline for the SSI 2025 meeting is coming up! Don't forget to submit your abstract by June 15th at swimm.se/ssi2025-abst....

🚨 We’re hiring a bioinformatics-focused PhD student for our ERC-funded project on recurrent GBM! Focus: tumor-supportive microenvironment 🔬 Experience with scRNA-seq, spatial transcriptomics & Python/R a plus. Must be self-motivated & driven. DM for details! Repost=❤️ lu.varbi.com/en/what:job/...

Curious about how it is to do research in Sweden? Below you find information gathered by the Swedish Research Council. www.vr.se/english/rese...

🧵5 Top Free Alternatives to BioRender for Scientific Illustrations! These five websites offer free scientific illustrations for biologists. Great for presentations, research papers and other research communication needs. Save and share the post!

Check out this new publication showing that TBX3 cooperates with Wnt/b-catenin to promote metastasis in colorectal cancer @pnas.org Congratulations to @claudiocantu81.bsky.social and team! @liucancer.bsky.social Bluetorial 👇🏼

Excited to have our latest research published in @jem.org this week and also highlighted by @natrevimmunol.nature.com @wehi-research.bsky.social @benjbroom.bsky.social

What a day! Hear about a few of our favorite sessions from Day 2 of #IMMUNOLOGY2025 in our latest episode. Listen here: bit.ly/432qmH6 #AAI2025

Interesting preprint on TCR-pMHC prediction and functional validation, with a great thread! 👇🏼 By the Shumacher Lab

Can't make it to #IMMUNOLOGY2025? Brenda and Jason will be recording from Honolulu to keep you up to date!🎙️ Our first daily episode will be released on May 4. Stay tuned! #AAI2025

One more to the list of factors tumors use to avoid immune recognition: Tumor-derived erythropoietin acts as an immunosuppressive switch in cancer immunity | Science www.science.org/doi/10.1126/...

Focused on improving relapsed/refractory T-ALL patient outcomes, Maciocia et al. identified CD21 as a promising target for CAR T cell therapy. bit.ly/4iG2uie   @nicolamaciocia.bsky.social 

Very proud of this study from my PhD student Medina @medina0396.bsky.social 👏🏻🎉 showing how the immune checkpoint receptor VISTA regulates macrophages in triple negative breast cancer to suppress T cells. @mcschmid.bsky.social @livunicancer.bsky.social @livuni-ismib.bsky.social rdcu.be/ekqtp

For more on CAR T cell therapy to overcome barriers in treating pediatric central nervous system tumors, read the review by #AACR25 speaker Andrea Timpanaro (along with @nickvitanza.bsky.social and colleagues) - online now in Cancer Discovery! doi.org/10.1158/2159...#AACR25

We all know how much the microenvironment matters! So grateful that the #TME field has so many fantastic - and supportive - women leaders 🙌 #AACR2025 🧪⚕️ #womeninscience #payitforward @theaacr.bsky.social